# Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

> **NCT00076375** · PHASE2 · COMPLETED · sponsor: **Nucryst Pharmaceuticals** · enrollment: 180 (—)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DRUG:** Nanocrystalline silver cream (NPI)

## Key facts

- **NCT ID:** NCT00076375
- **Lead sponsor:** Nucryst Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 180 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076375, "Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00076375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*